Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,426 | 141 | 55.6% |
| Consulting Fee | $1,240 | 1 | 20.1% |
| Unspecified | $1,169 | 6 | 19.0% |
| Education | $328.75 | 5 | 5.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,696 | 30 | $0 (2024) |
| LEO Pharma Inc. | $1,338 | 8 | $0 (2024) |
| GENZYME CORPORATION | $666.74 | 38 | $0 (2024) |
| Allergan, Inc. | $560.13 | 17 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $446.50 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $279.96 | 7 | $0 (2024) |
| UCB, Inc. | $219.77 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $214.48 | 3 | $0 (2021) |
| Dermavant Sciences, Inc. | $182.27 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $126.29 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,104 | 39 | ABBVIE INC. ($1,394) |
| 2023 | $1,781 | 18 | LEO Pharma Inc. ($1,260) |
| 2022 | $160.14 | 6 | Allergan, Inc. ($62.26) |
| 2021 | $168.46 | 8 | GENZYME CORPORATION ($91.77) |
| 2020 | $303.84 | 14 | SANOFI-AVENTIS U.S. LLC ($99.99) |
| 2019 | $762.15 | 24 | Allergan Inc. ($258.89) |
| 2018 | $701.82 | 30 | GENZYME CORPORATION ($202.33) |
| 2017 | $182.62 | 14 | AbbVie, Inc. ($55.50) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $93.72 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.12 | General |
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $21.34 | General |
| 11/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.00 | General |
| Category: Immunology | ||||||
| 09/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $46.62 | General |
| Category: DERMATOLOGY | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.49 | General |
| 08/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Immunology | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.30 | General |
| Category: Immunology | ||||||
| 08/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Genetic Disease | ||||||
| 07/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $26.70 | General |
| Category: DERMATOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 06/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Dermatology | ||||||
| 04/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: DERMATOLOGY | ||||||
| 04/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: Immunology | ||||||
| 04/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | ABBVIE INC. | $1,154 | 5 |
| A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence | ABBVIE INC. | $14.82 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,770 | 2,563 | $384,073 | $142,660 |
| 2022 | 22 | 1,676 | 2,534 | $361,265 | $135,903 |
| 2021 | 24 | 1,818 | 2,820 | $394,972 | $151,508 |
| 2020 | 24 | 1,633 | 2,448 | $307,519 | $126,972 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 438 | 567 | $93,776 | $36,113 | 38.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 202 | 238 | $48,826 | $19,691 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 211 | $49,503 | $19,607 | 39.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 242 | 270 | $50,682 | $17,138 | 33.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 35 | 41 | $23,040 | $9,638 | 41.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 176 | 232 | $27,731 | $8,333 | 30.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $12,269 | $4,900 | 39.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 79 | 114 | $10,938 | $4,605 | 42.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 38 | $17,197 | $3,770 | 21.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 97 | 530 | $6,132 | $2,722 | 44.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,421 | $2,255 | 35.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 46 | $4,658 | $1,950 | 41.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 14 | 17 | $4,098 | $1,764 | 43.0% |
| 10040 | Acne surgery | Office | 2023 | 15 | 17 | $3,601 | $1,551 | 43.1% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 17 | 19 | $4,302 | $1,530 | 35.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 14 | $3,780 | $1,373 | 36.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $3,893 | $1,304 | 33.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $3,306 | $1,270 | 38.4% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 11 | $2,481 | $913.59 | 36.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 27 | 28 | $2,869 | $902.07 | 31.4% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 14 | 15 | $2,797 | $735.99 | 26.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,592 | $565.02 | 35.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 30 | 36 | $180.00 | $29.18 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 395 | 519 | $85,837 | $34,385 | 40.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 221 | 263 | $53,954 | $21,860 | 40.5% |
About Dr. Mary Veremis-Ley, DO
Dr. Mary Veremis-Ley, DO is a Dermatology healthcare provider based in Clinton Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235133703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Veremis-Ley, DO has received a total of $6,164 in payments from pharmaceutical and medical device companies, with $2,104 received in 2024. These payments were reported across 153 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,426).
As a Medicare-enrolled provider, Veremis-Ley has provided services to 6,897 Medicare beneficiaries, totaling 10,365 services with total Medicare billing of $557,043. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Clinton Township, MI
- Active Since 06/13/2005
- Last Updated 07/28/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1235133703
Products in Payments
- ADBRY (Biological) $1,300
- BOTOX (Biological) $1,269
- DUPIXENT (Biological) $739.64
- DUPIXENT (Drug) $412.51
- Bimzelx (Biological) $219.77
- VTAMA (Drug) $182.27
- TREMFYA (Drug) $170.54
- BOTOX COSMETIC (Biological) $153.69
- DUPIXENT DUPILUMAB INJECTION (Biological) $137.07
- Humira (Biological) $109.60
- STELARA (Biological) $99.00
- COSENTYX (Biological) $72.99
- SKYRIZI (Biological) $69.22
- Zoryve (Drug) $43.00
- Sotyktu (Drug) $36.89
- Seysara (Drug) $36.70
- AMELUZ (Drug) $36.59
- COSENTYX (Drug) $27.81
- Alcortin A (Drug) $27.79
- OPZELURA (Drug) $25.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Clinton Township
Dr. Davide Iacobelli, Md, MD
Dermatology — Payments: $514,967
Tiffany Cukrowski, Do, DO
Dermatology — Payments: $33,197
Dr. Heather Orkwis, D.o, D.O
Dermatology — Payments: $7,507
Ethan Sagher, Md, MD
Dermatology — Payments: $6,199
Reema Habra, Md, MD
Dermatology — Payments: $5,430
Tudor Puiu, Md, MD
Dermatology — Payments: $4,847